Low-Dose Ponatinib Is A Good Option In Chronic Myeloid Leukemia Patients Intolerant To Previous Tkis

Caocci, Giovanni;
2020-01-01
2020
Inglese
AMERICAN JOURNAL OF HEMATOLOGY
95
10
260
263
4
WOS:000545701100001
2-s2.0-85087634058
32557788
Esperti anonimi
scientifica
no
Iurlo, Alessandra; Cattaneo, Daniele; Malato, Alessandra; Accurso, Vincenzo; Annunziata, Mario; Gozzini, Antonella; Scortechini, Anna Rita; Bucelli, C ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
17
reserved
Files in This Item:
File Size Format  
LOW-DOSE PONATINIB IS A GOOD OPTION IN CHRONIC MYELOID LEUKEMIA PATIENTS INTOLERANT TO PREVIOUS TKIs .pdf

Solo gestori archivio

Type: versione pre-print
Size 957.76 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
957.76 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie